Organization | City of Los Angeles

City of Los Angeles Report issue

Government Phase 3

Organization Overview

First Clinical Trial

2005

NCT00059332

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2005

Timeline

NOW

Now

Alternative names

Los Angeles City Emergency Medical Service, Co-Principal Investigator | Los Angeles County Department of Public Health

Active Ingredients

Drugs in Phase 3 Trials (2)

magnesium sulfate (Tis-U-Sol) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Stroke (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 1
# of Trial APIs: 2